Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience.

MLA

Oleinikov, Kira, et al. “Long-Term Outcomes in MEN-1 Patients with Pancreatic Neuroendocrine Neoplasms: An Israeli Specialist Center Experience.” Endocrine, vol. 68, no. 1, Apr. 2020, pp. 222–29. EBSCOhost, https://doi.org/10.1007/s12020-020-02217-4.

APA

Oleinikov, K., Uri, I., Jacob, H., Epshtein, J., Benson, A., Ben-Haim, S., Atlan, K., Tal, I., Meirovitz, A., Maimon, O., Lev-Cohain, N., Mazeh, H., Glaser, B., Gross, D. J., & Grozinsky-Glasberg, S. (2020). Long-term outcomes in MEN-1 patients with pancreatic neuroendocrine neoplasms: an Israeli specialist center experience. Endocrine, 68(1), 222–229. https://doi.org/10.1007/s12020-020-02217-4

Chicago

Oleinikov, Kira, Inbal Uri, Harold Jacob, Julia Epshtein, Ariel Benson, Simona Ben-Haim, Karine Atlan, et al. 2020. “Long-Term Outcomes in MEN-1 Patients with Pancreatic Neuroendocrine Neoplasms: An Israeli Specialist Center Experience.” Endocrine 68 (1): 222–29. doi:10.1007/s12020-020-02217-4.